Back to search

Article

Protective Effects of Dietary Flavonoid, Apigenin Against Sorafenib-Induced Oxidative, Genetic, and Hepato-Renal Toxicity in Swiss Albino Mice

2022-03-16

Abstract excerpt

Sorafenib is an FDA-approved chemotherapeutic drug used as standard therapy for advanced-stage cancers. However, Sorafenib-induced multiple adverse effects is a major limitation that directly impacts patients' physical and physiological well-being. Therefore, it is vital to identify agents that can lessen the associated adverse effects and enhance efficacy. Apigenin, a dietary plant-flavone, is a bioactive-compoun...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
e07eb639-e4ec-58b4-8238-1324e63c8923
DOI
10.21203/rs.3.rs-1441781/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Protective Effects of Dietary Flavonoid, Apigenin Against Sorafenib-Induced Oxidative, Genetic, and Hepato-Renal Toxicity in Swiss Albino MiceDOI 10.21203/rs.3.rs-1441781/v1
Select a neighboring publication to make it the new centre.